ENDV — Endonovo Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Endonovo Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.379	0.019	0.013	0.086	0
Net Total Accounts Receivable
Net Total Receivables	0.003	0.023	0.001	0.001	0
Prepaid Expenses
Total Current Assets	0.383	0.063	0.046	0.095	0.016
Net Property, Plant And Equipment	0.007	0.006	0.002	0	—
Net Intangible Assets
Total Assets	4.24	3.27	2.61	2.01	1.28
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.5	23.6	16.8	17.7	33.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	15.6	23.8	17	17.8	33.5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-11.4	-20.5	-14.4	-15.8	-32.2
Total Liabilities & Shareholders' Equity	4.24	3.27	2.61	2.01	1.28
Total Common Shares Outstanding
Total Preferred Shares Outstanding